• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human RIPOR2 Polyclonal Antibody

The antibody against RIPOR2 was raised in rabbit using the Recombinant Human Rho family-interacting cell polarization regulator 2 protein (1-250AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, IHC.

ADC-16034A

The antibody against RIPOR2 was raised in rabbit using the Recombinant Human Rho family-interacting cell polarization regulator 2 protein (1-250AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, IHC.

$299.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-16034A ClonalityPolyclonal
Host SpeciesRabbitTarget NameRIPOR2
Target SynonymsAb2 162 antibody; C6orf32 antibody; DIFF48 antibody; FA65B_HUMAN antibody; Fam65b antibody; KIAA0386 antibody; PL48 antibody; Protein FAM65B antibodyFormLiquid
Species ReactivityHumanIsotypeIgG
Storage Buffer0.01M PBS, 0.03% Proclin 300; Constituents: 50% Glycerol, PH 7.4Purification Method>95%, Protein G purified
ConjugateNon-conjugatedApplicationELISA, IHC
StorageUpon receipt

Immunogen Information


Immunogen DescriptionRecombinant Human Rho family-interacting cell polarization regulator 2 protein (1-250AA)Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDQ9Y4F9
Background Information
  • Uniprot Id

    Q9Y4F9

  • Target Species

    Human

  • Target Name

    RIPOR2

  • Target Full Name

    Rho family-interacting cell polarization regulator 2

  • Target Function

    Acts as an inhibitor of the small GTPase RHOA and plays several roles in the regulation of myoblast and hair cell differentiation, lymphocyte T proliferation and neutrophil polarization. Inhibits chemokine-induced T lymphocyte responses, such as cell adhesion, polarization and migration. Involved also in the regulation of neutrophil polarization, chemotaxis and adhesion. Required for normal development of inner and outer hair cell stereocilia within the cochlea of the inner ear. Plays a role for maintaining the structural organization of the basal domain of stereocilia. Involved in mechanosensory hair cell function. Required for normal hearing.; Acts as an inhibitor of the small GTPase RHOA. Plays a role in fetal mononuclear myoblast differentiation by promoting filopodia and myotube formation. Maintains naive T lymphocytes in a quiescent state.

  • Target Involvement

    Deafness, autosomal recessive, 104 (DFNB104)

  • Target Subcellular Location

    Cytoplasm. Cytoplasm, cytoskeleton. Cell projection, filopodium. Cell projection, stereocilium. Cell projection, stereocilium membrane. Apical cell membrane.; [Isoform 1]: Cytoplasm.; [Isoform 2]: Cytoplasm.

  • Target Protein Families

    RIPOR family

  • Target Tissue Specificity

    Expressed in primary fetal mononuclear myoblast. Expressed strongly in naive T lymphocytes. Expressed weakly in activated T lymphocytes (at protein level). Expressed in blood cells and adult tissues of hematopoietic origin, such as the secondary lymphoid

  • Target Synonyms

    PL48; DFNA21; DIFF40; DIFF48; FAM65B; MYONAP; C6orf32; DFNB104

  • Target Background

    This gene encodes an atypical inhibitor of the small G protein RhoA. Inhibition of RhoA activity by the encoded protein mediates myoblast fusion and polarization of T cells and neutrophils. The encoded protein is a component of hair cell stereocilia that is essential for hearing. A splice site mutation in this gene results in hearing loss in human patients.

Inquire Rabbit anti-Human RIPOR2 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification